Composite mantle-cell lymphoma and classical Hodgkin lymphoma

被引：21
|
作者：
Hayes, SJ [1 ]
Banerjee, SS
Cook, Y
Houghton, JB
Menasce, LP
机构：
[1] Salford Royal Hosp, Dept Histopathol, Salford, Lancs, England
[2] Christie Hosp, Dept Histopathol, Manchester, Lancs, England
[3] Christie Hosp, Dept Cytogenet, Manchester, Lancs, England
[4] Salford Royal Hosp, Dept Haematol, Salford, Lancs, England
来源：
HISTOPATHOLOGY | 2006年 / 48卷 / 05期
关键词：
D O I：
10.1111/j.1365-2559.2005.02296.x
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：621 / 623
页数：4
相关论文
共 50 条
  • [31] Is bortezomib an effective treatment for indolent or mantle-cell non-Hodgkin's lymphoma?
    Bertrand Coiffier
    [J]. Nature Clinical Practice Oncology, 2005, 2 : 388 - 389
  • [32] Mantle-Cell Lymphoma-Taming the Tiger
    Shields, Carol L.
    Lally, Sara E.
    Shields, Jerry A.
    [J]. JAMA OPHTHALMOLOGY, 2017, 135 (12) : 1374 - 1375
  • [33] The ATM gene in the pathogenesis of mantle-cell lymphoma
    Stilgenbauer, S
    Schaffner, C
    Winkler, D
    Ott, G
    Leupolt, E
    Bentz, M
    Möller, P
    Müller-Hermelink, HK
    James, MR
    Lichter, P
    Döhner, H
    [J]. ANNALS OF ONCOLOGY, 2000, 11 : 127 - 130
  • [34] Duodenal polyyposis disclosing mantle-cell lymphoma
    Moulin, O
    Boucher, E
    Samson, T
    Coutant, G
    Helie, C
    Algayres, JP
    [J]. GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2002, 26 (11): : 1055 - 1057
  • [35] A BTK INHIBITOR IS EFFECTIVE IN MANTLE-CELL LYMPHOMA
    不详
    [J]. CANCER DISCOVERY, 2013, 3 (08) : 839 - 839
  • [36] Composite lymphoma associating diffuse large B-cell lymphoma with classical Hodgkin lymphoma
    Lauwers, Mailis
    Daubie, Valery
    Farhat, Hussein
    Rocq, Laureen
    Trepant, Anne-Laure
    Vanoverschelde, Laura
    [J]. EJHAEM, 2022, 3 (04): : 1409 - 1411
  • [37] Toward New Treatments for Mantle-Cell Lymphoma?
    Zucca, Emanuele
    Bertoni, Francesco
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (06): : 571 - 572
  • [38] Is bortezomib an effective treatment for indolent or mantle-cell non-Hodgkin's lymphoma?
    Coiffier, B
    [J]. NATURE CLINICAL PRACTICE ONCOLOGY, 2005, 2 (08): : 388 - 389
  • [39] The effect of Rituximab on patients with follicular and mantle-cell lymphoma
    Ghielmini, M
    Schmitz, SFH
    Bürki, K
    Pichert, G
    Betticher, DC
    Stupp, R
    Wernli, M
    Lohri, A
    Schmitter, D
    Bertoni, F
    Cerny, T
    [J]. ANNALS OF ONCOLOGY, 2000, 11 : 123 - 126
  • [40] Outcome of Deferred Initial Therapy in Mantle-Cell Lymphoma
    Martin, Peter
    Chadburn, Amy
    Christos, Paul
    Weil, Karen
    Furman, Richard R.
    Ruan, Jia
    Elstrom, Rebecca
    Niesvizky, Ruben
    Ely, Scott
    DiLiberto, Maurizio
    Melnick, Ari
    Knowles, Daniel M.
    Chen-Kiang, Selina
    Coleman, Morton
    Leonard, John P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (08) : 1209 - 1213
12345